Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model

Study limitation reported by the research below: “All patients were managed at a single tertiary academic cancer center (MSK), which may not reflect risk distributions or monitoring practices in community oncology settings.”